Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.
Br J Haematol. 2017 Aug;178(4):534-546. doi: 10.1111/bjh.14707. Epub 2017 Apr 25.
Br J Haematol. 2017.
PMID: 28439875
Free article.
However, we recently showed that the serine/threonine kinase PDPK1 and its substrate RPS6KA3 (also termed RSK2) are universally active in MM, and play pivotal roles in myeloma pathophysiology. ...Introduction of miR-375 reduced PDPK1 expression in human myelo …
However, we recently showed that the serine/threonine kinase PDPK1 and its substrate RPS6KA3 (also termed RSK2) are universall …
Expression pattern of the Rsk2, Rsk4 and Pdk1 genes during murine embryogenesis.
Kohn M, Hameister H, Vogel M, Kehrer-Sawatzki H.
Kohn M, et al.
Gene Expr Patterns. 2003 May;3(2):173-7. doi: 10.1016/s1567-133x(03)00004-8.
Gene Expr Patterns. 2003.
PMID: 12711546
The ribosomal S6 kinase family members RSK2 (RPS6KA3) and RSK4 (RPS6KA6) belong to the group of X chromosomal genes, in which defects cause unspecific mental retardation (MRX) in humans. ...
The ribosomal S6 kinase family members RSK2 (RPS6KA3) and RSK4 (RPS6KA6) belong to the group of X chromosomal genes, in which defects …
Item in Clipboard
Cite
Cite